Expected number in right hand side of -, found Q on line 1 in file '~/Content/themes/pandemic/default.less': []: /beginning of file [1]: @utm_campaign: APAC-2020-Q3-nCoVWuhanWebinar; ------------------------^ [2]: @utm_medium: email; 2019-nCoV

+44 (0)20 8762 8008
Change Language
[Close]
- English
  
  Japanese
  
  English
Home
Overview
- Pandemic
- Bird Flu
Subscribers
Locations
Newsroom
- News
- Editorials
- FAQs

Quick Links

COVID-19

Public Access

Interactive COVID-19 Data by Location

COVID-19 Case Count Trackers

Education and Communication

COVID-19 FAQs and External Resources

COVID-19 Videos

Member Access

Travel Restrictions, Flight Operations and Screening

COVID-19 Digital Passports

Scientific Update

COVID-19 FAQs

COVID-19 Vaccine

COVID-19 Vaccine FAQs

COVID-19 Variants

COVID-19 Testing

COVID-19 Treatment

Use of Face Masks by the General Public

COVID-19 Travel Advice

COVID-19 Disease and Prevention Article

Sign up for Emails and Alerts

Premium Services Member Access

COVID-19 Manager Advice

COVID-19 Case Definitions used by different authorities

Pandemic Local Impact Tool

COVID-19 Communication Material

COVID-19 Modelling

COVID-19 Useful Links

…
3
4
5
6
7
…

COVID-19 update: Widespread rise in cases
India // 17 April, 2023
An increase in COVID-19 cases has been reported in several states...
COVID-19
Newer Covid-19 subvariant XBB.1.16 reported more frequently
United States // 14 April, 2023
CDC monitors the variant proportions weekly...
COVID-19
COVID-19 Vaccine Update – AstraZeneca vaccine not available for use
Australia // 04 April, 2023
Vaxzevria COVID-19 vaccine unavailable for use
COVID-19
EMA recommends Bimervax approval as COVID-19 booster vaccine
31 March, 2023
COVID-19 booster EMA recommendations...
COVID-19
WHO interim guidelines for COVID-19 public health and social measures
31 March, 2023
The World Health Organization (WHO) has published a new 34-page interim guidance on the use of public health and social measures...
COVID-19, General Articles
WHO updates COVID-19 vaccination guidance
28 March, 2023
WHO updates guidance on vaccines...
COVID-19
WHO COVID-19 weekly updates, March 2023
23 March, 2023
WHO updates on the global COVID-19 situation...
COVID-19
COVID-19 vaccine update – First mRNA vaccine approved
China // 23 March, 2023
Chinese regulators have approved its first mRNA vaccine ...
COVID-19
Omicron strain with feature of two subvariants identified
China // 18 March, 2023
A case of Omicron recombinant strain
COVID-19
WHO statement on updates to COVID-19 definitions and tracking system for variants of concern and variants of interest
16 March, 2023
Updates to WHO COVID definitions and tracking...
COVID-19
Researchers are developing guidelines to treat long COVID
15 March, 2023
10-20% of people infected with COVID-19 will continue to experience symptoms months later...
COVID-19
COVID-19 negative test result no longer required for travellers from China
China // France // 13 March, 2023
Restrictions removed for those travelling from China to France...
COVID-19
COVID-19 pre-travel testing no longer required for travellers from China
China // United States // 11 March, 2023

COVID-19
EU/EEA COVID-19 vaccination strategies and deployment
07 March, 2023
Over 970 million vaccine doses administered...
COVID-19
ECDC de-escalates some Omicron subvariants as variants of concerns
03 March, 2023
BA.2, BA.4, and BA.5 are no longer circulating in the EU...
COVID-19
WHO COVID-19 weekly updates, February 2023
22 February, 2023
WHO updates on the global COVID-19 situation...
COVID-19
WHO updates statement on the use of variant-containing COVID-19 vaccines
22 February, 2023
WHO released further guidance on COVID vaccinations...
COVID-19
Moderna’s bivalent COVID-19 vaccine authorised as booster for children
Canada // 20 February, 2023
Health Canada has authorised Moderna’s bivalent COVID-19 vaccine for use as a booster dose for children six years...
COVID-19
Covid-19 case notification rates remain at the lowest levels in the past year
09 February, 2023

COVID-19
Post-acute COVID-19: Study compares long-term symptoms of COVID-19 and common respiratory infections
09 February, 2023
Long term health implications, known as "post-acute sequelae (PASC) of SARS-CoV-2", continue to be reported...
COVID-19

…
3
4
5
6
7
…

Additional data provided by

© 2024 International SOS